COURT-RULING ·Filed Jul 16, 2026

ANIP

ANI PHARMACEUTICALS INC
NEUTRAL
Impact 2/10
Horizonweeks Processed2mo ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

Monitor for future filings or news releases regarding the outcome of this case; the opinion text was not available for analysis. The case may involve patent or commercial disputes, but no material impact can be assessed at this time.

DirectionNeutral
Confidencelow
Horizonweeks
Latest settled — T+20d
ANIP ▼ -8.73% at T+20d
NEUTRAL call ✗ call lost -8.73% · α vs SPY -12.35% · entry $81.92 → $74.77
Next anchor: T+60d in 6d
Latest observation: T+52 -6.17% FF3 residual α
Entry anchored
Jul 15, 03:59 PM ET
via exchange tick
T+1d
-3.32%
call -3.32% · α -2.33%
$79.20
settled 3mo ago
T+5d
-4.14%
call -4.14% · α -2.47%
$78.53
settled 2mo ago
T+20d
-8.73%
call -8.73% · α -12.35%
$74.77
settled 7w ago
T+60d
—
call — · α —
—
in 6d

Price Chart

Loading chart...

Executive Summary

ANI Pharmaceuticals Inc. (ANIP) is involved in a lawsuit against CG Oncology Inc. in Delaware Superior Court (case N24C-03-022 SKR CCLD). The opinion text for the July 16, 2026 ruling was unavailable, preventing analysis of the outcome or financial impact. The ruling's direction and materiality remain unknown.

Court Ruling Details

Ruling Date
Jul 16, 2026
Court
Delaware Superior Court
Court Level
District
Case Type
other
Ruling Type
other
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW

Key Facts

  • Case: ANI Pharmaceuticals Inc. v. CG Oncology Inc. in Delaware Superior Court
  • Ruling date: 2026-07-16
  • Opinion text was unavailable for analysis

Financial Impact

Not specified

Risk Factors

  • Uncertainty due to unavailable opinion text
  • Potential adverse ruling could impact ANIP's operations or financials

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (13 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-a3d1f282d5-ANIP
21 reports for ANIP
Performance horizon
43% Hit rate 3 of 7 directional calls best @ T+60▲ +8.88%Apr 8, 2026
Filters
Rows
Reports for ANIP — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$72.11 $77.91▲ +8.04%▲ +7.23%$71.97 (−0.19%)
Sep 1, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$73.06 $71.46▼ −2.19%▼ −1.23%$71.97 (−1.49%)
Aug 24, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$74.17 $73.25▼ −1.24%▼ −1.71%$71.97 (−2.97%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$74.77 $77.32▲ +3.41%▲ +5.37%$71.97 (−3.74%)
Aug 7, 2026
8w ago
8-K
BULLISH ★ 6/10
$78.25 $76.54▼ −2.19%▼ −2.58%$71.97 (−8.03%)
Jul 16, 2026
11w ago
Court Ruling
NEUTRAL ★ 2/10
$81.92 $78.53▼ −4.14%▼ −2.47%$71.97 (−12.15%)
Jul 13, 2026
11w ago
Press Release
BULLISH ★ 6/10
$81.08 $79.20▼ −2.32%▼ −1.53%$71.97 (−11.24%)
Jun 15, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$83.00 $82.94▼ −0.07%▲ +2.16%$71.97 (−13.29%)
Jun 11, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$81.65 $80.52▼ −1.38%▼ −1.82%$71.97 (−11.86%)
May 21, 2026
19w ago
8-K
NEUTRAL ★ 3/10
$82.72 $76.71▼ −7.27%▼ −8.92%$71.97 (−13.00%)
Showing 10 of 21

US Market Status

Market Open — Closes in 2h 19m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access